| MEDAX | MEDCX | MEDAX / MEDCX | |
| Total Expense Ratio | 1.07 | 1.82 | 59% |
| Annual Report Gross Expense Ratio | 1.08 | 1.83 | 59% |
| Fund Existence | 28 years | 24 years | - |
| Gain YTD | 2.817 | 2.430 | 116% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.64B | 7.64B | 100% |
| Annual Yield % from dividends | 5.17 | 4.43 | 117% |
| Returns for 1 year | 10.12 | 9.28 | 109% |
| Returns for 3 years | 31.35 | 28.49 | 110% |
| Returns for 5 years | 13.61 | 9.44 | 144% |
| Returns for 10 years | 42.04 | 31.77 | 132% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| EIPFX | 19.77 | 0.26 | +1.33% |
| EIP Growth and Income Investor | |||
| MLVOX | 18.78 | 0.23 | +1.24% |
| MFS Low Volatility Equity R2 | |||
| DISRX | 23.11 | 0.21 | +0.92% |
| BNY Mellon International Stock Fund I | |||
| HNDRX | 90.13 | 0.11 | +0.12% |
| Horizon Defined Risk Investor | |||
| JDMRX | 132.01 | -0.05 | -0.04% |
| Janus Henderson Enterprise R | |||